Maze Therapeutics Inc.

NASDAQ: MAZE · Real-Time Price · USD
13.49
0.14 (1.05%)
At close: Aug 15, 2025, 3:59 PM
13.50
0.07%
After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
52.23M -100.42M -114.94M
Depreciation & Amortization
3.3M 4.09M 3.82M
Stock-Based Compensation
9.65M 8.75M 6.74M
Other Working Capital
-1.32M -6.71M 541K
Other Non-Cash Items
12.3M 7.07M 8.42M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-1.52M -6.32M -3.24M
Operating Cash Flow
75.95M -86.83M -99.2M
Capital Expenditures
-1.15M -441K -1.97M
Cash Acquisitions
n/a n/a -1.2M
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-1.15M -441K -3.17M
Debt Repayment
24.48M 16.18M n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-2.42M n/a 154K
Financial Cash Flow
92.85M 16.39M 1.73M
Net Cash Flow
167.65M -70.88M -100.64M
Free Cash Flow
74.81M -87.27M -101.17M